NOVEL IMMUNOTHERAPY APPROACH FOR RESCUING INADEQUATE RESPONSES AND RESISTANCE TO TREATMENT FOR PATIENTS WITH MULTIPLE MYELOMA

Grant number: CRFMD17002 | Funding period: 2018 - 2022

Active

Researchers